Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells $23,722.88 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) insider Nicholas Hollmeyer Lynton sold 6,464 shares of the company’s stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $3.67, for a total transaction of $23,722.88. Following the completion of the transaction, the insider now owns 91,771 shares of the company’s stock, valued at approximately $336,799.57. This trade represents a 6.58 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Cardlytics Trading Down 8.4 %

NASDAQ CDLX traded down $0.32 on Monday, reaching $3.49. 2,033,344 shares of the company were exchanged, compared to its average volume of 1,212,448. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The business’s fifty day moving average price is $3.93 and its 200 day moving average price is $4.85. The stock has a market capitalization of $177.37 million, a P/E ratio of -0.57 and a beta of 1.53. Cardlytics, Inc. has a fifty-two week low of $2.89 and a fifty-two week high of $20.52.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The firm had revenue of $67.06 million during the quarter, compared to analyst estimates of $57.77 million. During the same quarter in the prior year, the firm posted ($0.26) earnings per share. Cardlytics’s quarterly revenue was down 15.1% on a year-over-year basis. Analysts forecast that Cardlytics, Inc. will post -1.52 earnings per share for the current year.

Institutional Trading of Cardlytics

Institutional investors have recently made changes to their positions in the company. RBF Capital LLC lifted its holdings in Cardlytics by 311.9% in the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock valued at $1,562,000 after acquiring an additional 369,620 shares during the last quarter. GSA Capital Partners LLP lifted its stake in shares of Cardlytics by 1,273.2% in the 3rd quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock valued at $1,223,000 after purchasing an additional 354,474 shares during the last quarter. Renaissance Technologies LLC raised its holdings in Cardlytics by 711.9% in the 2nd quarter. Renaissance Technologies LLC now owns 351,035 shares of the company’s stock valued at $2,882,000 after buying an additional 307,800 shares during the period. Jacobs Levy Equity Management Inc. boosted its stake in Cardlytics by 56.0% during the third quarter. Jacobs Levy Equity Management Inc. now owns 317,644 shares of the company’s stock worth $1,016,000 after buying an additional 113,966 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Cardlytics by 7.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock valued at $3,371,000 after acquiring an additional 73,484 shares during the period. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on CDLX shares. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Thursday, November 7th. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, November 6th. Finally, Evercore ISI started coverage on shares of Cardlytics in a research report on Friday, October 11th. They set an “in-line” rating and a $4.00 price objective for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Cardlytics presently has a consensus rating of “Hold” and a consensus price target of $6.92.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.